Drug repurposing of metformin for Alzheimer’s disease: Combining causal inference in medical records data and systems pharmacology for biomarker identification
Data Availability
US RPDR. Researchers can obtain an anonymized version of the study dataset from the authors upon request and completion of the MGB Health data use agreement for the use of RPDR data. This agreement ensures the privacy of MGB patients and compliance with US regulatory standards and has been approved by the MGB IRB. UK CPRD. According to the UK Data Protection Act, information governance restrictions (to protect patient confidentiality) prevent data sharing via public deposition. Therefore, CPRD data that support the findings of this study are not publicly available. Data extracts can be requested by applying to the Clinical Practice Research Datalink for data spanning the years 2000 to 2018 (https://www.cprd.com). The code to process the data is available from the authors upon request. Metformin/Glyburide RNA-seq. https://www.synapse.org/#!Synapse:syn22213067
Subject Area
- Addiction Medicine (354)
- Allergy and Immunology (679)
- Anesthesia (182)
- Cardiovascular Medicine (2687)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12318)
- Forensic Medicine (10)
- Gastroenterology (771)
- Genetic and Genomic Medicine (4161)
- Geriatric Medicine (390)
- Health Economics (685)
- Health Informatics (2699)
- Health Policy (1010)
- Hematology (365)
- HIV/AIDS (861)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3935)
- Nursing (213)
- Nutrition (586)
- Oncology (2073)
- Ophthalmology (596)
- Orthopedics (243)
- Otolaryngology (308)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1131)
- Primary Care Research (462)
- Public and Global Health (6583)
- Radiology and Imaging (1424)
- Respiratory Medicine (877)
- Rheumatology (414)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (55)
- Transplantation (191)
- Urology (170)